An in vivo model to assess factors that may stimulate the generation of an immune reaction to erythropoietin

International Immunopharmacology
Mary H RyanFrancis X Farrell

Abstract

The incidence of pure red cell aplasia (PRCA) in patients with chronic kidney disease associated with the subcutaneous (s.c.) administration of epoetin alfa (EPREX) began to increase in 1998. As part of an intensive investigation into the reasons for this increase, in vivo models were developed to assess the ability of potential causative factors to stimulate an immune response to recombinant human erythropoietin (rHuEPO). It was difficult to generate anti-EPO antibodies in mice. In animals injected with rHuEPO alone, anti-EPO antibodies were either absent or present at very low levels. The addition of an adjuvant to the immunization protocol was able to increase both the frequency of occurrence and titer of the immune response and resulted in the generation of anti-EPO antibodies that, in most cases, recognized both human and mouse EPO. Some mice exhibited a reduction in hematocrit, suggesting neutralization of endogenous EPO by anti-EPO antibodies. To evaluate the primary lead identified in the technical investigation, leachates from the uncoated syringe stoppers of EPREX syringes, a surrogate antigen (chicken egg albumin, OVA) was used to avoid possible interferences that could arise from the use of an endogenous protein lik...Continue Reading

References

Oct 1, 1991·Proceedings of the National Academy of Sciences of the United States of America·G L SemenzaS E Antonarakis
Feb 21, 1997·The Journal of Biological Chemistry·F P BarboneL S Mulcahy
Oct 19, 2000·Food and Chemical Toxicology : an International Journal Published for the British Industrial Biological Research Association·S K ClausenG D Nielsen
Nov 24, 2001·International Journal of Pharmaceutics·Søren T LarsenPeter Thygesen
Jun 27, 2002·Trends in Pharmacological Sciences·Jean-Charles Ryff, Huub Schellekens
Jul 18, 2002·Nature Reviews. Drug Discovery·Huub Schellekens
Jan 17, 2004·Pharmaceutical Research·Suzanne HermelingWim Jiskoot
Apr 13, 2005·Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association·Katia BovenNicole Casadevall
Jul 20, 2005·Pharmaceutical Research·Annabelle P VillalobosGeorge A Heavner
Sep 10, 2015·Cancer Biotherapy & Radiopharmaceuticals·Mahdi Habibi-AnbouhiMohammad Ali Shokrgozar

❮ Previous
Next ❯

Citations

Oct 13, 2006·Nature Biotechnology·Basant SharmaKatia Boven
Apr 28, 2011·Journal of Pharmaceutical Sciences·Jared S BeeMariana N Dimitrova
Sep 17, 2015·Journal of Pharmaceutical Sciences·Merry ChristieJohn F Carpenter
Feb 20, 2009·Journal of Pharmaceutical Sciences·Robert MuellerHanns-Christian Mahler
Jun 13, 2008·Kidney International·Sai Ram Keithi-ReddyAjay K Singh
Oct 2, 2015·Chemical & Pharmaceutical Bulletin·Tomonobu UchinoYoshiyuki Kagawa
Mar 6, 2007·Biotechnology Advances·Basant Sharma
Sep 23, 2014·Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association·Iain C MacdougallUNKNOWN PRIMS study group
Dec 20, 2007·Current Opinion in Nephrology and Hypertension·Iain C Macdougall
Feb 1, 2008·Proteomics. Clinical Applications·Harold TjalsmaDorine W Swinkels
Dec 13, 2007·Journal of Molecular Recognition : JMR·Rebecca L Rich, David G Myszka
Dec 14, 2007·Clinical Journal of the American Society of Nephrology : CJASN·Ajay K Singh
Jul 8, 2020·Expert Opinion on Biological Therapy·Anurag S RathoreAnkita Bhargava
Jun 6, 2021·Journal of Pharmaceutical Sciences·Ariane SchröterMichael Jahn

❮ Previous
Next ❯

Related Concepts

Related Feeds

Avian Influenza: Innate Immune Adjuvant

Adjuvants systems that are added to vaccines against avian influenza have be explored to enhance the innate immune system response against the virus. Here is the latest research on avian influenza and the innate immune adjuvant.

Avian Influenza: Innate Immune Adjuvant (ASM)

Adjuvants systems that are added to vaccines against avian influenza have be explored to enhance the innate immune system response against the virus. Here is the latest research on avian influenza and the innate immune adjuvant.